| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6655263ba4852e71280f7529b0065f3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
2019-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b602e1206d784044c90e1c96c5ab3e4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f31db7c7aee389586142596ede5b252b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d339c6047c42b1f3290032bc8617ec08 |
| publicationDate |
2021-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021102674-A1 |
| titleOfInvention |
Application of combination of ampk-targeting inhibitor/sirna and proteasome inhibitor in anticancer |
| abstract |
An application of a combination of an AMPK-targeting inhibitor and/or siRNA and a proteasome inhibitor in anticancer. The proteasome inhibitor can significantly promote the tumor cell death induced by the AMPK-targeting inhibitor and/or siRNA. |
| priorityDate |
2019-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |